CorVel Corporation (CRVL) Price Prediction 2026–2050

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.

The company also offers a range of network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. CorVel offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims.

CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

CorVel Corporation, CRVL, operates in the Financial Services category. The current price is $62.74 and the market capitalization is $3.22B. It ranks 1661st. The stock’s current technical tone is bullish with a 14‑day RSI of 60, a 50‑day simple moving average of $56.10, and a 200‑day simple moving average of $67.56.

The price action sits between a support level of $54.30 and a resistance of $64.26, with a 30‑day trading range from $54.23 to $72.58. The stock exhibits an annualized volatility of 40%.

Looking ahead, the forecast shows the average price moving from the current level toward higher values over time, with 2026 averaging $62.74 and subsequent years showing a bullish trajectory.

The multi‑year forecast shows a steady rise in the average price with expanding upside. In 2026 the min is $46.00, the avg is $62.74, and the max is $91.97, with a neutral sentiment and 0% ROI. By 2027 the avg rises to $81.06 and the max to $105.61, with a 29.2% ROI and a bullish tilt.

From 2028 through 2030 the averages climb to $90.84, $104.28, and $? (the data shows $104.28 as 2030 avg) with corresponding ROIs of 44.8%, 66.2% and bullish sentiment. Specifically: 2028 min $71.80, avg $90.84, max $121.91, ROI 44.8%; 2029 min $77.14, avg $99.36, max $136.53, ROI 58.4%; 2030 min $79.69, avg $104.28, max $146.19, ROI 66.2%.

The trajectory continues with 2031 avg $119.28, 2032 avg $132.46, 2033 avg $155.27, 2034 avg $183.22, and 2035 avg $183.52, with ROIs of 90.1%, 111.1%, 147.5%, 192.0%, and 192.5% respectively, all labeled bullish.

Longer horizon points include 2040 avg $287.74 (ROI 358.6%) and 2050 avg $543.88 (ROI 766.9%), both with bullish sentiment. These figures illustrate substantial upside potential if the forecast path holds, though they remain estimates rather than guarantees and are subject to market risks and volatility.